grant

Advancing Precision Medicine for ARDS and Sepsis

Organization UNIVERSITY OF CALIFORNIA, SAN FRANCISCOLocation SAN FRANCISCO, UNITED STATESPosted 1 Apr 2025Deadline 31 Mar 2032
NIHUS FederalResearch GrantFY2025AddressAdrenal Cortex HormonesAwardBiologicalCause of DeathClinicalClinical DataClinical ResearchClinical StudyClinical TreatmentClinical TrialsCollaborationsCorticoidsCorticosteroidsCritical CareCritical IllnessCritically IllData BasesDatabasesDiagnosisDiagnostic FindingsDrug TherapyExperimental ModelsFluid TherapyFoundationsFunctional MetagenomicsGoalsHandHeterogeneityHospital MortalityHumanImmune responseIn-house MortalitiesInfectionInflammatoryInhospital MortalityInvestigatorsLifeMechanical ventilationMedicineMetagenomicsModelingModern ManNHLBINational Heart, Lung, and Blood InstituteOutcomePathway interactionsPatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPharmacological TreatmentPharmacotherapyPhenotypePlasma ProteinsPositionPositioning AttributeProspective StudiesRecoveryResearchResearch PersonnelResearchersSamplingSepsis and ARDSSigns and SymptomsSimvastatinSupportive TherapySupportive careSyndromeSynvinolinTherapeutic AgentsTimeTranslational ResearchTranslational Scienceactivated Protein Cacute respiratory distress syndrome caused by sepsisbiologicbiological heterogeneitybody fluid balance therapyclinical careclinical heterogeneityclinical interventionclinical therapycohortdata basedata modelingdrug interventiondrug treatmentdruggable targeteffective therapyeffective treatmentexperiencehandshigh dimensional datahost responseimmune system responseimmunoresponseimprovedimproved outcomein silicoin vivoinnovateinnovationinnovativemechanical respiratory assistmechanically ventilatedmodel of datamodel the datamodeling of the datamolecular phenotypemultidimensional datamultidimensional datasetsnew approachesnovelnovel approachesnovel strategiesnovel strategypathogenpathwaypatient oriented outcomespharmaceutical interventionpharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticspre-clinical studyprecision medicineprecision-based medicinepreclinical studyprotein biomarkersprotein markersresponseresponse to therapyresponse to treatmentsepsis ARDSsepsis acute respiratory distress syndromesepsis and acute respiratory distress syndromesepsis associated acute respiratory distress syndromesepsis induced ARDSsepsis induced acute respiratory distress syndromesepsis related acute respiratory distress syndrometargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttherapeutic responsetherapy responsetraittranslation researchtranslational investigationtreatment effecttreatment responsetreatment responsivenesstrial regimentrial treatment
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Abstract:
The acute respiratory distress syndrome (ARDS) and sepsis are common causes of death in critically ill

patients, yet both are clinical syndromes defined by non-specific signs and symptoms which encompass major

clinical and biological heterogeneity. Pre-clinical studies have identified numerous promising therapeutic agents

for both ARDS…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Advancing Precision Medicine for ARDS and Sepsis — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | UNITED STATES | Apr 2025 | Dev Procure